Mazdak Ganjalikhani hakemi

About Mazdak Ganjalikhani hakemi

Mazdak Ganjalikhani hakemi, With an exceptional h-index of 28 and a recent h-index of 22 (since 2020), a distinguished researcher at Isfahan University of Medical Sciences, specializes in the field of immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Bioactive peptides: an alternative therapeutic approach for cancer management

Potential Diagnostic Value of Abnormal Pyroptosis Genes Expression in Myelodysplastic Syndromes (MDS): A Primary Observational Cohort Study

TIM-3/Galectin-9 interaction and glutamine metabolism in AML cell lines, HL-60 and THP-1

Nanoparticles as potent agents for treatment of Schistosoma Infections: A Systematic Review

Non-infectious meningitis and CNS demyelinating diseases: A conceptual review

The influence of KIR gene polymorphisms and KIR-ligand binding on outcomes in hematologic Malignancies following haploidentical stem cell transplantation: A comprehensive review

PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia

Potential role of intracellular recycling in acute myeloid leukemia chemoresistance

Mazdak Ganjalikhani hakemi Information

University

Position

Associate Professor

Citations(all)

2045

Citations(since 2020)

1447

Cited By

1042

hIndex(all)

28

hIndex(since 2020)

22

i10Index(all)

54

i10Index(since 2020)

48

Email

University Profile Page

Isfahan University of Medical Sciences

Google Scholar

View Google Scholar Profile

Mazdak Ganjalikhani hakemi Skills & Research Interests

immunology

Top articles of Mazdak Ganjalikhani hakemi

Title

Journal

Author(s)

Publication Date

Bioactive peptides: an alternative therapeutic approach for cancer management

Nooshin Ghadiri

Moslem Javidan

Shima Sheikhi

Özge Taştan

Alessandro Parodi

...

2024/1/24

Potential Diagnostic Value of Abnormal Pyroptosis Genes Expression in Myelodysplastic Syndromes (MDS): A Primary Observational Cohort Study

International Journal of Hematology-Oncology and Stem Cell Research

Mohammad Soltani

Mohammad Jafar Sharifi

Parvin Khalilian

Mehran Sharifi

Pardis Nematollahi

...

2024/4/16

TIM-3/Galectin-9 interaction and glutamine metabolism in AML cell lines, HL-60 and THP-1

BMC cancer

Hooriyeh Shapourian

Mustafa Ghanadian

Nahid Eskandari

Abolfazl Shokouhi

Gülderen Yanikkaya Demirel

...

2024/1/24

Nanoparticles as potent agents for treatment of Schistosoma Infections: A Systematic Review

Pegah Shakib

Masoomeh Zivdaria

Amal Khudair Khalaf

Abdolrazagh Marzban

Mazdak Ganjalikhani-Hakemi

...

2023/8/22

Non-infectious meningitis and CNS demyelinating diseases: A conceptual review

M Etemadifar

M Fereidan-Esfahani

N Sedaghat

PK Kargaran

AR Mansouri

...

2023/6/1

The influence of KIR gene polymorphisms and KIR-ligand binding on outcomes in hematologic Malignancies following haploidentical stem cell transplantation: A comprehensive review

Tahereh Bakhtiari

Mohammad Ahmadvand

Arash Salmaninejad

Afshin Ghaderi

Marjan Yaghmaie

...

2023/12/1

PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia

BMC cancer

Mojdeh Soltani

Mustafa Ghanadian

Behrooz Ghezelbash

Abolfazl Shokouhi

Andrey A Zamyatnin Jr

...

2023/5/16

Potential role of intracellular recycling in acute myeloid leukemia chemoresistance

Hamidreza Zalpoor

Maryam Bakhtiyari

Abdullatif Akbari

Fatemeh Aziziyan

Hooriyeh Shapourian

...

2023/8/9

The role of miRNAs from mesenchymal stem/stromal cells-derived extracellular vesicles in neurological disorders

Morteza Jafarinia

Majid Reza Farrokhi

Mazdak Ganjalikhani Hakemi

William C Cho

2023/1

TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines

Frontiers in Immunology

Mahnaz Rezaei

Mustafa Ghanadian

Behrooz Ghezelbash

Abolfazl Shokouhi

Alexandr V Bazhin

...

2023/11/10

OPEN ACCESS EDITED AND REVIEWED BY

New-generation vaccines and novel vaccinal strategies against infectious diseases of livestock, wild and companion animals

Botond Z Igyártó

Jesús Hernández

Edgar Alonso Melgoza-González

Lorena Bustamante-Córdova

2023/8/25

PD-1/PD-L1 Interaction Regulates BCL2, KI67, BAX, and CASP3, Altering Proliferation, Survival, and Apoptosis in Acute Myeloid Leukemia

Iranian Journal of Allergy, Asthma and Immunology

Mojdeh Soltani

Mahshid Vosoughi

Mazdak Ganjalikhani-Hakemi

Hoorieh Shapoorian

Pezhman Beshkar

...

2023/11/7

The immunosuppressive tumor microenvironment and strategies to revert its immune regulatory milieu for cancer immunotherapy

Frontiers in Immunology

Mazdak Ganjalikhani Hakemi

Gülderen Yanikkaya Demirel

Yangqiu Li

Nair Jayakumar

2023/6/26

Investigation of KIR/HLA relationship and other clinical variables after T-cell-replete haploidentical bone marrow transplantation in patients with acute myeloid leukemia (AML)

BMC immunology

Tahereh Bakhtiari

Mohammad Ahmadvand

Marjan Yaghmaie

Alireza Sadeghi

Seied Asadollah Mousavi

...

2023/6/20

Morphology-dependent immunomodulatory coating of hydroxyapatite/PEO for magnesium-based bone implants

ACS Applied Materials & Interfaces

Safoura Farshid

Mahshid Kharaziha

Hossein Salehi

Mazdak Ganjalikhani Hakemi

2023/10/13

Cellular and Molecular Mechanisms of Immune Checkpoint Blockers in Anti-leukemia/Lymphoma Immune Therapy

Frontiers in Oncology

Mazdak Ganjalikhani-Hakemi

Ling Xu

Andrey A Zamyatnin Jr

Alexandr V Bazhin

2022/3/7

Clinical Combinatorial Treatments Based on Cancer Vaccines: Combination with Checkpoint Inhibitors and Beyond

Mojdeh Soltani

Lyudmila V Savvateeva

Mazdak Ganjalikhani-Hakemi

Andrey A Zamyatnin

2022/8/1

Role of rare immune cells in common variable immunodeficiency

Mojdeh Soltani

Mahnaz Rezaei

Saba Fekrvand

Mazdak Ganjalikhani‐Hakemi

Hassan Abolhassani

...

2022/2

Flt3-ITD mutated acute myeloid leukemia patients and COVID-19: potential roles of autophagy and HIF-1α in leukemia progression and mortality

Human Cell

Hamidreza Zalpoor

Mahnaz Rezaei

Sheida Yahyazadeh

Mazdak Ganjalikhani-Hakemi

2022/7

Comparison of laboratory methods for the clinical follow up of checkpoint blockade therapies in leukemia: Current status and challenges ahead

Basak Aru

Mojdeh Soltani

Cemil Pehlivanoglu

Ege Gürlü

Mazdak Ganjalikhani-Hakemi

...

2022/1/27

See List of Professors in Mazdak Ganjalikhani hakemi University(Isfahan University of Medical Sciences)

Co-Authors

H-index: 108
Nima Rezaei

Nima Rezaei

Tehran University of Medical Sciences

H-index: 69
Hassan Abolhassani

Hassan Abolhassani

Karolinska Institutet

H-index: 40
Ahmadreza Jamshidi

Ahmadreza Jamshidi

Tehran University of Medical Sciences

H-index: 39
Mahdi Mahmoudi

Mahdi Mahmoudi

Tehran University of Medical Sciences

H-index: 31
Abbas Rezaei

Abbas Rezaei

Isfahan University of Medical Sciences

H-index: 22
Gholam Ali Kardar

Gholam Ali Kardar

Tehran University of Medical Sciences

academic-engine